Sareum’s small molecule drug discovery expertise builds value by developing drug candidates, focused on cancer and autoimmune disease, for licencing to pharmaceutical and biotechnology companies.
Find out more about us
29 November 2016
21 November 2016
02 November 2016
24 October 2016
Find out more
Sareum actively seeks collaboration partners for its research programmes.
Sareum has an innovative pipeline of drug development candidates.
Proactive Investors, May 2016 (Slides)
Share price data
Regulatory News Service (RNS)
Sareum LimitedUnit 2A, Langford ArchLondon Road, PampisfordCambridge CB22 3FXUnited Kingdom
tel: +44 (0) 1223 497700fax: +44 (0) 1223 497701
Sareum brochure PDF (1.2MB)
Annual report PDF 2016 (1.0MB)
AGM Notice, Nom & Proxy 2016 (93K)